Hilleman Laboratories (India)

Recent papers from Hilleman Laboratories (India)

1. Life-cycle performance of RC bridges exposed to vehicle overloading and corrosion-fatigue degradationStructure and Infrastructure Engineering · 2025
2. A thermostable, dry formulation inactivated Hikojima whole cell/cholera toxin B subunit oral cholera vaccineVaccine · 2023
3. Exploring State-Of-The-Art Advances in Targeted Nanomedicines for Managing Acute and Chronic Inflammatory Lung DiseasesNanomedicine · 2022
4. Influence of ground motion duration on the seismic vulnerability of aging highway bridgesStructure and Infrastructure Engineering · 2021
5. A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in BangladeshVaccine · 2021
6. Review on the Recent Advances on Typhoid Vaccine Development and Challenges AheadClinical Infectious Diseases · 2020
7. A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infantsHuman Vaccines & Immunotherapeutics · 2019
8. Development and pre-clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Neisseria meningitidis serogroup CVaccine · 2019
9. Inhibition ELISA as a putative tool for the identification and quantification of meningococcal A and X polysaccharides at various stages of vaccine developmentJournal of Immunological Methods · 2019
10. Time to tap the potential of synthetic conjugate vaccine technology as the future of conjugate vaccine marketJournal of Bacteriology & Mycology Open Access · 2019
11. Rotavirus vaccine efficacy: current status and areas for improvementHuman Vaccines & Immunotherapeutics · 2018
12. Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trialThe Lancet Infectious Diseases · 2018
13. An Exploration of the Feasibility of Introducing Rota Vaccine Into the Routine Epi Schedule of BangladeshPublic Health of Indonesia · 2017
14. Synthesis and immunochemical evaluation of a novel Neisseria meningitidis serogroup A tetrasaccharide and its conjugateOrganic Chemistry Frontiers · 2017
15. Synthesis of a tetrasaccharide and its glycoconjugate corresponding to the capsular polysaccharide of Neisseria meningitidis serogroup X and its immunochemical studiesRSC Advances · 2015
16. Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domainmAbs · 2012